ScholarIQanswers from OpenAlex
Perioperative Nivolumab in Resectable Lung Cancer
PaperCitations, authors & open-access status
Perioperative Nivolumab in Resectable Lung Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Perioperative Nivolumab in Resectable Lung Cancer have?
ScholarIQcitation count
Perioperative Nivolumab in Resectable Lung Cancer has 482 citations in the OpenAlex counts ScholarIQ stores.
When was Perioperative Nivolumab in Resectable Lung Cancer published?
ScholarIQyear
Perioperative Nivolumab in Resectable Lung Cancer has 2024 year in the ScholarIQ index.
What is the open-access status of Perioperative Nivolumab in Resectable Lung Cancer?
ScholarIQoa status
Perioperative Nivolumab in Resectable Lung Cancer has green oa status in the ScholarIQ index.
What is the DOI of Perioperative Nivolumab in Resectable Lung Cancer?
ScholarIQdoi
The DOI for Perioperative Nivolumab in Resectable Lung Cancer is on the source record.
What is the PMID of Perioperative Nivolumab in Resectable Lung Cancer?
ScholarIQpmid
The PMID for Perioperative Nivolumab in Resectable Lung Cancer is on the source record.
What is the OpenAlex record for Perioperative Nivolumab in Resectable Lung Cancer?
ScholarIQopenalex
The OpenAlex for Perioperative Nivolumab in Resectable Lung Cancer is on the source record.